| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Buckwheat Sprouts — edible young seedlings produced by germination of buckwheat, principally common buckwheat (Fagopyrum esculentum) and Tartary buckwheat (Fagopyrum tataricum). They are a flavonoid- and polyphenol-rich functional food rather than a standardized drug or single-molecule therapeutic. Common buckwheat sprouts characteristically contain rutin, orientin, isoorientin, vitexin, isovitexin, quercetin-related glycosides, chlorogenic acid and other phenolic compounds, whereas Tartary buckwheat sprouts are generally more rutin-dominant and can contain substantially higher rutin concentrations. Germination markedly alters the phytochemical profile relative to ungerminated grain. Composition varies with species, sprouting duration, illumination, cultivar and cultivation conditions. Buckwheat sprouts also contain the phototoxic naphthodianthrone derivatives fagopyrins, making excessive consumption of green sprouts potentially more problematic than consumption of buckwheat grain. Primary mechanisms (ranked):
Bioavailability / PK relevance: Buckwheat sprouts are a complex food matrix and do not have a single definable pharmacokinetic profile. Rutin has relatively poor absorption as intact rutin and largely reaches the colon, where microbial metabolism produces quercetin and other metabolites that subsequently enter the circulation. Human pharmacokinetic studies demonstrate delayed and highly variable systemic exposure after rutin-containing foods. The C-glycosyl flavones orientin, isoorientin, vitexin and isovitexin contribute additional exposure but their concentrations vary substantially among sprout preparations. Consequently, phytochemical content cannot be directly converted into systemic therapeutic exposure. In-vitro vs systemic exposure relevance: Concentrated methanolic, ethanolic, polyphenol-rich or subcritical-water sprout extracts used in many cell studies can produce concentrations substantially different from those achievable by eating ordinary fresh sprouts. Cancer-cell and mechanistic extract studies should therefore not be interpreted as demonstrating equivalent systemic anticancer activity from dietary consumption. Food-level effects are more plausibly mediated by repeated intestinal exposure, metabolites and modulation of antioxidant, inflammatory and metabolic pathways. Clinical evidence status: Predominantly preclinical and nutritional. Evidence includes compositional studies, biochemical assays, cultured-cell studies and animal models of inflammation, oxidative stress, dyslipidemia and hypertension. Direct randomized human therapeutic trials of buckwheat sprouts themselves are sparse or absent in the literature identified, and there is no established clinical anticancer indication. Buckwheat sprouts should therefore be classified as a functional food / preclinical nutraceutical rather than an established treatment. Safety is generally compatible with food use, but large or repetitive consumption of green sprouts may increase fagopyrin exposure and risk of photosensitization; one experimental assessment proposed keeping fresh sprout intake below approximately 40 g/day, although a validated human toxicological threshold has not been established. Major Bioactive Ingredients in Buckwheat Sprouts
Harvest interpretation: Approximately day 3 favors maximum concentrations of the C-glycosyl flavones isoorientin, orientin, isovitexin and vitexin. Approximately day 6 provides a better overall compromise because rutin and total measured phenols peak at this stage. In one common buckwheat study, total phenols reached 162.9 mg/100 g fresh weight at day 6. Tartary Buckwheat Sprout Flour Compared with Fresh Sprouts
Practical interpretation: Tartary buckwheat sprout flour is a concentrated and convenient alternative to fresh sprouts, particularly when rutin is the primary target. Freeze-dried or gently dried sprout powder is preferable because excessive heat can reduce flavonoid content. Sprout flour should not be confused with ordinary Tartary buckwheat grain flour, which generally contains substantially less rutin. Buckwheat Sprout Mechanisms
|
| Source: |
| Type: |
| Glutathione (GSH) is a thiol antioxidant that scavenges reactive oxygen species (ROS), resulting in the formation of oxidized glutathione (GSSG). Decreased amounts of GSH and a decreased GSH/GSSG ratio in tissues are biomarkers of oxidative stress. Glutathione is a powerful antioxidant found in every cell of the body, composed of three amino acids: cysteine, glutamine, and glycine. It plays a crucial role in protecting cells from oxidative stress, detoxifying harmful substances, and supporting the immune system. cancer cells can have elevated levels of glutathione, which may help them survive in the oxidative environment created by the immune response and chemotherapy. This can make cancer cells more resistant to treatment. While glutathione can be obtained from certain foods (like fruits, vegetables, and meats), its absorption from supplements is debated. Some people take N-acetylcysteine (NAC) or other precursors to boost glutathione levels, but the effects on cancer prevention or treatment are still being studied. Depleting glutathione (GSH) to raise reactive oxygen species (ROS) is a strategy that has been explored in cancer research and therapy. Many cancer cells have altered redox states and may rely on GSH to survive. Increasing ROS levels can induce stress in these cells, potentially leading to cell death. Certain drugs and compounds can deplete GSH levels. For example, agents like buthionine sulfoximine (BSO) inhibit the synthesis of GSH, leading to its depletion. Cancer cells tend to exhibit higher levels of intracellular GSH, possibly as an adaptive response to a higher metabolism and thus higher steady-state levels of reactive oxygen species (ROS). "...intracellular glutathione (GSH) exhibits an astounding antioxidant activity in scavenging reactive oxygen species (ROS)..." "Cancer cells have a high level of GSH compared to normal cells." "...cancer cells are affluent with high antioxidant levels, especially with GSH, whose appearance at an elevated concentration of ∼10 mM (10 times less in normal cells) detoxifies the cancer cells." "Therefore, GSH depletion can be assumed to be the key strategy to amplify the oxidative stress in cancer cells, enhancing the destruction of cancer cells by fruitful cancer therapy." The loss of GSH is broadly known to be directly related to the apoptosis progression. |
| 7953- | BuckWS, | RT, | Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:470 Target#:137 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid